Raymond James advises PAGODA and Adiuva Capital on their sale of ascopharm to Point Rouge

By on Januar 18, 2019

THE DEAL

  • Private equity firms PAGODA and Adiuva Capital (the „Shareholders“) have sold 100% of the share capital in Germany-based Trappetrinn GmbH as well as its subsidiaries ascopharm GmbH and revomed GmbH (together „ascopharm“ or „the Company“) to point-rouge GmbH („Point Rouge“)
  • ascopharm is a leading one-stop-shop for affordable high-quality consumer health products „Made in Germany“
  • The Company has 40+ years of product development experience and a high brand recognition across Europe and internationally
  • With its 360+ SKUs for the entire body and all age groups ascopharm covers the entire well-being space and has become the go-to-brand particularly for the strong 50+ consumer segment in Germany as well as a leading supplier to duty-free shops across Europe

DEAL RATIONALE

  • The deal enables Point Rouge to complement its consumer product portfolio by tapping into the highly attractive and rapidly growing consumer health market with ascopharm’s strong brand portfolio and product development expertise
  • Point Rouge’s established platform will be ideal to accelerate the Company’s growth in both B2C and B2B segments in Europe and beyond

DEAL BACKGROUND

  • Raymond James acted as exclusive financial advisor to the Shareholders of ascopharm
  • Financial terms of the transcation are not disclosed

RAYMOND JAMES HEALTHCARE INVESTMENT BANKING 

  • Raymond James is a leading global Healthcare M&A advisor
  • In the last 12 months we have closed more than 15 Healthcare transactions
  • More than 20 Healthcare bankers across offices in North America and Europe
  • Deep sector expertise in Consumer Healthcare with an experienced and dedicated team

About ascopharm

ascopharm is a leading one-stop-shop for highest quality nutritional supplements, cosmetics and OTC drugs „made in Germany“. Founded in 1977, the Company has a 40+ years brand history with a strong recognition in Europe and internationally; offering 360+ SKUs for the entire body and all age groups. The Company’s products are sold via mail-order and e-commerce under its brands Sovita, ascopharm Best Edition and Märchenhof to consumers. B2B customers are served through revomed, Sovita Advanced as well as private label offerings. For more information, please visit www.ascopharm.de.

About PAGODA

PAGODA is a private equity investment platform backed primarily by European institutions and specializes in growth capital for Chinese technology superstars as well as buyouts of Western companies seeking growth in the Chinese market through PAGODA’s strategic market resources.

About Adiuva Capital 

Since 2011 we have supported mid-sized enterprises with capital to help them achieve their goals – this mandate derives from our name (lat. adiuvare: to help, aid, assist). Adiuva invests in mid-sized enterprises that are primarily based in the German-speaking region. We are fortunate to provide the entrepreneurial capital of our German investors to attractive growth companies on a long-term basis. By doing so, we are completely independent from any institutional interests. We are engaged in a broad variety of industries and able to realize a wide spectrum of transaction types. Adiuva manages assets of about EUR 300 Mio. and is currently invested in 13 mid-sized enterprises. For more information, please visit www.adiuvacapital.de

About Point Rouge

Point Rouge is an online shop specializing in cosmetics and beauty products. It offers an extensive selection of over 15,000 products from exclusive brands covering makeup, fragrances, body & hair care and accessoires. Located in München Grünwald, the company has 30 employees focusing on delivering high-quality content through various communication channels, including online, as well as magazine & social media. For more information, please visit www.point-rouge.de

About Raymond James Investment Banking

Raymond James offers one of the most highly regarded equity offering and advisory practices. Since 2015, we have participated in raising nearly $165 billion in capital for our corporate clients. During this same time, we completed more than 450 advisory assignments, including more than 390 M&A buy-side or sell-side advisory assignments. Raymond James was recently  named „Investment Banking Firm of the Year“ by The M&A Advisor and „Investment Bank of the Year“ by Global M&A Network.  For more information, please visit www.raymondjames.com


Mehr Informationen zu dieser und vielen anderen Transaktionen erhalten Sie HIER


Über 25.000 recherchierte Transaktionen seit 2005 - Legen Sie sich Ihre eigene Datenbank zu!


You must be logged in to post a comment Login